Superficial mycoses in immunodepressed patients (AIDS)

Clinics in Dermatology

Volumn 28, Issue 2, 2010, Pages 217-225

  Ramos e Silva, Marcia ^a   Lima, Cíntia Maria Oliveira ^a   Schechtman, Regina Casz ^a   Trope, Beatriz Moritz ^a   Carneiro, Sueli ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

[4 (2,4 DICHLOROPHENYL) 1,3 DITHIOLAN 2 YLIDENE](1 IMIDAZOLYL)ACETONITRILE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BUTENAFINE; CLOTRIMAZOLE; EBERCONAZOLE; FLUCONAZOLE; GRISEOFULVIN; IANOCONAZOLE; IMIDAZOLE DERIVATIVE; ISOCONAZOLE; ITRACONAZOLE; KERATOLYTIC AGENT; KETOCONAZOLE; NYSTATIN; OXICONAZOLE; PYRROLE DERIVATIVE; RILOPIROX; TERBINAFINE; TIOCONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANDIDA; CANDIDIASIS; DERMATOMYCOSIS; DERMATOPHYTE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYALOHYPHOMYCOSIS; MALASSEZIA; MYCOSIS; NONHUMAN; NOTE; ONYCHOMYCOSIS; OROPHARYNX CANDIDIASIS; PHAEOHYPHOMYCOSIS; PRIORITY JOURNAL; SEBORRHEIC DERMATITIS; SKIN CANDIDIASIS; THRUSH; TINEA; TINEA NIGRA; TINEA PEDIS; TINEA VERSICOLOR;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDIASIS; DERMATOMYCOSES; DRUG COMBINATIONS; HUMANS; INCIDENCE; PIEDRA; RISK FACTORS; TINEA;

EID: 77950270068     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.12.008     Document Type: Note

References (90)

1. Vélez R.L. Infección por VIH y enfermedades parasitarias. Enf Emerg 2003, 5:9-12.
2. Jensen B.L., Weismann K., Sindrup J.H., Sondergaard J., Schmidt K. Incidence and prognostic significance of skin disease in patients with HIV/AIDS: a 5-year observational study. Acta Derm Venereol 2000, 80:140-143.
3. Patton L.L. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000, 90:182-188.
4. Raju P.V., Rao G.R., Ramani T.V., Vandana S. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Int J Dermatol 2005, 44:646-649.
5. Venkatesan P., Perfect J.R., Myers S.A. Evaluation and management of fungal infections in immunocompromised patients. Dermatol Ther 2005, 18:44-57.
6. Hoepelman I.M., Dupont B. Oral candidiasis: the clinical challenge of resistance and management. Int J Antimicrob Agents 1996, 6:155-159.
7. Trope B.M., Lenzi M.E. Infecção pelo HIV. Fundamentos de dermatologia 2009, 1003-1027. Atheneu, Rio de Janeiro. M. Ramos-e-Silva, M.C.R. Castro (Eds.).
8. Johnson R.A. Dermatophyte infections in human immune deficiency virus (HIV) disease. J Am Acad Dermatol 2000, 43:S135-S142.
9. Chen T., Cockerell C. Cutaneous manifestations of HIV infection and HIV-related disorders. Dermatology 2008, 1165-1181. Elsevier, New York. 2nd ed. J. Bolognia, J. Jorizzo, R. Rapini (Eds.).
10. Conant M.A. Fungal infections in immunocompromised individuals. Dermatol Clin 1996, 14:155-162.
11. Wright S.W., Johnson R.A. Human immunodeficiency virus in women: mucocutaneous manifestations. Clin Dermatol 1997, 15:93-111.
12. Fichtenbaum C.J., Powderly W.G. Recurrent oral candidiasis in HIV-infected patients. Infect Med 1994, 11:191-200.
13. Arribas J.R., Hernandez-Albujar S., Gonzalez-Garcia J.J., et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 2000, 14:979-985.
14. Como J.A., Dismukes W.E. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994, 330:263-272.
15. Tomimori J. Micoses superficiais. Fundamentos de dermatologia 2009, 875-893. Atheneu, Rio de Janeiro. M. Ramos-e-Silva, M.C.R. Castro (Eds.).
16. Rex J.H., Pfaller M.A., Rinaldi M.G., Polak A., Galgiani J.N. Antifungal susceptibility testing. Clin Microbial Rev 1993, 6:367-381.
17. Barchiesi F., Colombo A.L., McGough D.A., Fothergill A.W., Rinaldi M.G. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1994, 38:1530-1533.
18. Horn C.A., Washburn R.G., Givner L.B., Peacock J.E., Pegram P.S. Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS. AIDS 1995, 9:533-534.
19. Gallagher J.C., MacDougall C., Ashley E.S., Perfect J.R. Recent advances in antifungal pharmacotherapy for invasive fungal infections. Expert Rev Anti Infect Ther 2004, 2:253-258.
20. Ruhnke M. Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment. Drugs 2004, 64:1163-1180.
21. Dupont B. Resistance trends in oral Candida infections: the clinical challenge. Clinician 1993, 11:1922.
22. Rinaldi M.G. Dermatophytosis: epidemiological and microbiological update. J Am Acad Dermatol 2000, 43:S120-S124.
23. Smith K.J., Skelton H.G., Yeager J., et al. Cutaneous findings in HIV-1 positive patients: a 42-month prospective study. J Am Acad Dermatol 1994, 31:746-754.
24. Garman M.E., Tyring S.K. The cutaneous manifestations of HIV infection. Dermatol Clin 2002, 20:193-208.
25. Nir-Paz R., Elinav H., Pierard G.E., et al. Deep infection by Trichophyton rubrum in an immunocompromised patient. J Clin Microbiol 2003, 41:5298-5301.
26. Squeo R.F., Beer R., Silvers D., Weitzman I., Grossman M. Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host. J Am Acad Dermatol 1998, 39:379-380.
27. Piraccini B.M., Tosti A. White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients. Arch Dermatol 2004, 140:696-701.
28. Lawry M.A., Haneke E., Strobeck K., Martin S., Zimmer B., Romano P.S. Methods for diagnosing onychomycosis: a comparative study and review of the literature. Arch Dermatol 2000, 136:1112-1116.
29. Elewski B.E., Leyden J., Rinaldi M.G., Atillasoy E. Office practice-based confirmation of onychomycosis: a US nationwide prospective survey. Arch Intern Med 2002, 162:2133-2138.
30. Cohen P.R., Scher R.K. Topical and surgical treatment of onychomycosis. J Am Acad Dermatol 1994, 31:S74-S77.
31. Gregory N. Special patient populations: onychomycosis in the HIV-positive patient. J Am Acad Dermatol 1996, 35:S13-S16.
32. Rinaldi M.G. Phaeohyphomycosis. Dermatol Clin 1996, 14:147-153.
33. Shivaswamy K.N., Pradhan P., Laxmisha C., Thappa D.M., Jayanthi S. Disseminated pheohyphomycosis. Int J Dermatol 2007, 46:278-281.
34. McGinnis M.R. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983, 8:1-16.
35. Costa R.O. Micoses subcutâneas e sistêmicas. Fundamentos de dermatologia 2009, 861-873. Atheneu, Rio de Janeiro. M. Ramos-e-Silva, M.C.R. Castro (Eds.).
36. Baykal C., Kazancioǧlu R., Büyükbabani N., et al. Simultaneous cutaneous and ungual altemariosis in a renal transplant recipient. Br J Dermatol 2000, 143:910-912.
37. Yehia M., Thomas M., Pilmore H., Van Der Merwe W., Dittmer I. Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients: three cases. Transplantation 2004, 77:140-142.
38. Fothergill A.W. Identification of dematiaceous fungi and their role in human disease. Clin Infest Dis 1996, 22:S179-S184.
39. Brandt M.E., Warnock D.W. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother 2003, 15:36-47.
40. Sharkey P.K., Graybill J.R., Rinaldi M.G., et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990, 23:577-586.
41. Jimenez C., Lumbreras C., Aguado J.M., et al. Successful treatment of mucor infection after liver or pancreas-kidney transplantation. Transplantation 2002, 73:476-480.
42. Sobera J.O., Elewski B.E. Fungal diseases. Dermatology 2008, 1135-1163. Elsevier, New York. 2nd ed. J. Bolognia, J. Jorizzo, R. Rapini (Eds.).
43. Hall V.C., Goyal S., Davis M.D., Walsh J.S. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature. Int J Dermatol 2004, 43:648-653.
44. Nucci M., Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002, 35:909-920.
45. Guarro J., Nucci M., Akiti T., Gené I. Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol 2000, 38:3460-3462.
46. Bodey G.P., Boktour M., Mays S., et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol 2002, 47:659-666.
47. Castro L.G. Cutaneous Paecilomyces lilacinus infection. J Am Acad Dermatol 1998, 39:516-517.
48. Guarro J., Gams W., Pujol I., Gene J. Acremonium species: new emerging fungal opportunists-in vitro antifungal susceptibilities and review. Clin Infect Dis 1997, 25:1222-1229.
49. Pontes Z.B., Lima Ede O., Oliveira N.M., dos Santos J.P., Ramos A.L., Carvalho M.F. Onychomycosis in Joao Pessoa City, Brazil. Rev Argent Microbiol 2002, 34:95-99.
50. Mattei D., Mordini N., Lo Nigro C., et al. Successful treatment of Acremonium fungemia with voriconazole. Mycoses 2003, 46:511-514.
51. Kan S.F., Tsai T.H., Hu C.H., Lee W.R. Cutaneous hyalohyphomycosis caused by Acremonium in an immunocompetent patient. Br J Dermatol 2004, 150:789-790.
52. Walsh T.J. Primary cutaneous aspergillosis-an emerging infection among immunocompromised patients. Clin Infect Dis 1998, 27:453-457.
53. Berman B., Poochareon V.N., Villa A.M. Novel dermatologic uses of the immune response modifier imiquimod 5% cream. Skin Therapy Lett 2002, 7:1-6.
54. Rinaldi M.G. Epidemiology of mycoses in the HIV-infected patient: clinical aspects. Int J Antimicrob Agents 1996, 6:131-134.
55. Crissey J.T., Lang H., Parish L.C. Manual of medical mycology 1995, 263. Blackwell Science, Cambridge.
56. Elmets C.A. Management of common superficial fungal infections in patients with AIDS. J Am Acad Dermatol 1994, 31:S60-S63.
57. Dompmartin D., Dompmartin A., Deluol A.M., Grosshans E., Coulaud J.P. Onychomycosis and AID: clinical and laboratory findings in 62 patients. Int J Dermatol 1990, 29:337-339.
58. Brandt M.E., Harrison L.H., Pass M., et al. Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 2000, 6:46-49.
59. Faergemann J., Hersle K., Nordin P. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil® derm gel. Dermatology 1997, 194:19-21.
60. Lacaz C.S., Porto E., Martins J.E.C. Micologia médica 1991, 695. Sarvier, São Paulo.
61. Mirhendi H., Makimura K., Zomorodian K., Yamada T., Sugita T., Yamaguchi H. A simple PCR-RFLP method for identification and differentiation of 11 Malassezia species. J Microbiol Methods 2005, 61:281-284.
62. Farr P.M., Schuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole. Lancet 1984, 2:1271-1272.
63. Wikler J.R., Nieboer C., Willemze R. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol 1992, 27:37-39.
64. Assaf R.R., Weil M.L. The superficial mycoses. Dermatol Clin 1996, 14:57-67.
65. Guého E., Smith M.T., de Hoog G.S., Billon-Grand G., Christen R. Batenburg-van der Vegte WH. Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek 1992, 61:289-316.
66. Gueho E., Improvisi L., de Hoog G.S. Dupont B. Trichosporon on humans: a practical account. Mycoses 1994, 37:3-10.
67. Sugita T., Nishikawa A., Shinoda T., Kume H. Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients. J Clin Microbiol 1995, 33:1368-1370.
68. Gupta A.K., Chaudhry M., Elewski B. Tinea corporis, tinea cruris, tinea nigra and piedra. Dermatol Clin 2003, 21:395-400.
69. Figueras M.J., Guarro J., Zaror L. Ultrastructural aspects of hair digestion in black piedra infection. J Med Vet Mycol 1997, 35:1-6.
70. Khandpur S., Reddy B. Itraconazole therapy for white piedra affecting scalp hair. J Am Acad Dermatol 2002, 47:415-418.
71. Gip L. Black piedra: the first case treated with terbinafina (Lamisil). Br J Dermatol 1994, 130(suppl 43):26-28.
72. Badali H., Carvalho V.O., Vicente V., et al. Cladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol 2009, 47:51-62.
73. Burke W.A. Tinea nigra: treatment with topical ketoconazol. Cutis 1993, 52:209-211.
74. Girmenia C., Arcese W., Micozzi A., Martino P., Bianco P., Morace G. Onychomycosis as a possible origin of disseminated Fusarium solani infection in a patient with severe aplastic anemia. Clin Infect Dis 1992, 14:1167.
75. Lima K.M., Castro C.M.B., Cambuim I., et al. Hongos filamentosos no dermatofitos: onicomicosis en cuatro pacientes infectados con el virus de la inmunodeficiencia humana. Rev Iberoam Micol 2008, 25:45-49.
76. Lesueur A., Salmon Ceron D., Corlieu P., Ginsburg C. Sicard D. Aspergillus niger osteitis of the middle ear in a patient with HIV infection. Presse Med 1997, 26:1098.
77. Mylonakis E., Barlam T.F., Flanigan T., Rich J.D. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest 1998, 114:251-262.
78. Paula J.S., Bryk A., Lauretti Filho A., Romão E. Secondary glaucoma associated with bilateral Aspergillus niger endophthalmitis in an HIV-positive patient: case report. Arq Bras Oftalmol 2006, 69:395-397.
79. Escobar M.L., Carmona J. Lesiones ungueales y cutáneas por Scytalidium dimidiatum en Medellín (Colombia). 1990-1999. Presentación de 128 casos y revisión del problema del nombre del agente. Iatreia 2000, 13:140-150.
80. Marriott D.J., Wong K.H., Aznar E., Harkness J.L., Cooper D.A., Muir D. Scytalidium dimidiatum and Lecythophora hoffmannii: unusual causes of fungal infections in a patient with AIDS. J Clin Microbiol 1997, 35:2949-2952.
81. Dunn J.J., Wolfe M.J., Trachtenberg J., Kriesel J.D., Orlandi R.R., Carroll K.C. Invasive fungal sinusitis caused by Scytalidium dimidiatum in a lung transplant recipient. J Clin Microbiol 2003, 41:5817-5819.
82. Padin C., Fernandez-Zeppenfeldt G., Yegres F., Richard-Yegres N. Scytalidium dimidiatum: hongo oportunista para el hombre y árboles de Mangifera indica en Venezuela. Rev Iberoam Micol 2005, 22:172-173.
83. Godoy P., Nunes F., Silva V., Tomimori-Yamashita J., Zaror L., Fischman O. Onychomycosis caused by Fusarium solani and Fusarium oxysporum in São Paulo, Brazil. Mycopathologia 2004, 157:287-290.
84. Brilhante R.S.N., Cordeiro R.A., Medrano D.J.A., et al. Onychomycosis in Ceará (Northeast Brazil): epidemiological and laboratory aspects. Mem Inst Oswaldo Cruz 2005, 100:131-135.
85. Calado N.B., Sousa F., Gomes N.O., Cardoso F.R., Zaror L.C., Milan E.P. Fusarium nail and skin infection: a report of eight cases from Natal, Brazil. Mycopathologia 2006, 161:27-31.
86. Torres-Rodriguez J.M., Sellart-Altisent M. Celulitis y onicomicosis proximal de ambos ortejos mayores producida por Fusarium solani. Rev Iberoam Micol 2006, 23:241-244.
87. Dignani M.C., Anaissie E. Human fusariosis. Clin Microbiol Infect 2004, 10:67-75.
88. López-Jodra O., Torres-Rodriguez J.M. Especies fúngicas poco comunes responsables de onicomicosis. Rev Iberoam Micol 1999, 16:S11-S15.
89. Arrese J.E., Piérard-Franchimont C., Piérard G.E. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol 1996, 18:1296-1298.
90. Rubin A.I., Bagheri B., Scher R.K. Six novel antimycotics. Am J Clin Dermatol 2002, 3:71-81.